Cancer Clinical Trials

A listing of Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17782 clinical trials
Featured trial
Healthy Volunteers Needed for an Upcoming Clinical Trial!

Altasciences LA, formerly WCCT Global (a clinical research organization located in Cypress, CA), is looking for healthy volunteers to participate in an upcoming clinical research trial of

Accepts healthy volunteers
  • 0 views
  • 19 Jul, 2022
  • 1 location
Featured trial
High Blood Pressure Clinical Research Study

Altasciences LA, formerly WCCT Global (a clinical research organization located in Cypress, CA), is looking for volunteers with uncontrolled high blood pressure for a clinical trial of an

Accepts healthy volunteers
  • 0 views
  • 19 Jul, 2022
  • 1 location
Featured trial
Healthy Male Research Study

Looking for males 18-65 years of age, non-smokers, no drug or alcohol in take within past 30 years, no history of cancer, hep, hiv, high cholesterol or high blood pressure. Restrictions apply.

  • 558 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People who have cancer tend to get sick more often. This is in part because of the cancer treatments they get. Because of this, they may get shingles

cancer
lymphoma
chronic lymphocytic leukemia
ibrutinib
acalabrutinib
  • 238 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL/SLL), Lymphoplasmacytic Lymphoma(LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma(SMZL)

, but patients may be asked to undergo these procedures for research purposes) Clinical information is collected and stored in a central databank. Patients whose cancer requires

cancer
lymphocytosis
lymphoma
lymphadenopathy
marginal zone lymphoma
  • 115 views
  • 15 Apr, 2019
  • 1 location
Featured trial
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Background: Chronic lymphocytic leukemia (CLL) is a cancer of white blood cells. It is also called small lymphocytic lymphoma (SLL). It causes tiredness, night sweats

thrombocytopenia
cancer
fludarabine
neutrophil count
anemia
  • 359 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Pilot Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Background: Chronic lymphocytic leukemia (CLL) and/or small lymphocytic lymphoma (SLL) are tumors of abnormal B cells that often affect elderly patients. Studies have

thrombocytopenia
fludarabine
anemia
monoclonal antibodies
fatigue
  • 169 views
  • 15 Apr, 2019
  • 1 location
Featured trial
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

  • 831 views
  • 23 Nov, 2020
  • 5 locations
Featured trial
Pelle-926-203 Study, a research study for adults 18 years of age and older with High Frequency Basal Cell Carcinoma.

A multicenter, randomized, double-blind, vehicle-controlled, phase 2 efficacy and safety study of Patidegib Topical Gel, 2% for adults with high frequency Basal Cell Carcinoma (HF-BCC) who are 18 years of age and older at the time of study enrollment.  The study comprises three periods: screening, treatment, and follow-up. Participation in …

  • 129 views
  • 23 Nov, 2020
  • 3 locations
Featured trial
GRAVITAS-309: A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

The purpose of this study is to assess the efficacy and safety of itacitinib in combination with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host disease (cGVHD).  

graft versus host disease
graft-versus-host disease
  • 121 views
  • 10 May, 2022
  • 1 location